BiotechTube
Home/Valneva/Thomas Lingelbach
TL

Thomas Lingelbach

Chief Executive Officer

Valneva

Roles

Chief Executive OfficeratValneva
Chief Executive OfficeratValneva SE

Therapeutic Areas

Infectious DiseasesTravel Health

Valneva Pipeline

DrugIndicationPhase
VLA15Lyme DiseasePhase 3
IXCHIQ (VLA1553)ChikungunyaMarketed
Shigella Vaccine CandidateShigellosisPhase 2
Zika Vaccine CandidateZika VirusPhase 2

Leadership Team at Valneva

PB
Peter Bühler
Chief Financial Officer
JC
Juan Carlos Jaramillo, M.D.
Chief Medical Officer
FG
Franck Grimaud
Chief Business Officer
FJ
Frédéric Jacotot
Chief Technical Operations Officer
J(
James (Jim) F. Cummings
General Counsel
View full Valneva profile